Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Vitrolife Q2 EBITDA Down At SEK 40 Million

July 13 (Reuters) - Vitrolife AB  VITR.ST :
    * INTERIM REPORT JANUARY - JUNE 2020: EXTENSIVE IMPACT OF
COVID-19
    * Q2 SALES SEK 209 MILLION VERSUS SEK 381 MILLION YEAR AGO
    * SALES WERE NEGATIVELY IMPACTED BY A DECREASE IN DEMAND DUE
TO
COVID-19
    * DEMAND WAS SIGNIFICANTLY HIGHER AT END OF QUARTER COMPARED
TO
BEGINNING OF QUARTER.
    * Q2 EBITDA SEK 40 MILLION VERSUS SEK 146 MILLION YEAR AGO
    * Q2 NET INCOME SEK 12 MILLION VERSUS SEK 95 MILLION YEAR
AGO

Source text for Eikon:  ID:nWkrmPgr2 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))

Recent news on Vitrolife AB

See all news